002082.SZ(002082.SZ)
002082.SZ
Wanbangde Pharmaceutical Holding Group Co., Ltd. operates primarily in the aluminum sector, focusing on the production and distribution of aluminum products in China. The company has faced significant revenue declines, driven by market volatility and competitive pressures, which have impacted its profitability metrics.
Wanbangde generates revenue through the sale of aluminum products, including ingots and extrusions, primarily to construction and automotive industries. The company benefits from its established supply chain and relationships with major industrial clients, although it faces pricing pressure due to overcapacity in the aluminum market.
Aluminum price fluctuations in the domestic market
Changes in government regulations affecting the aluminum industry
Demand from construction and automotive sectors
Global supply chain disruptions
Overcapacity in the aluminum market leading to price wars
Regulatory changes aimed at reducing carbon emissions impacting production processes
Emerging competitors from lower-cost regions such as Southeast Asia
Technological advancements by competitors that improve production efficiency
Negative operating margins leading to potential liquidity issues
Dependence on fluctuating aluminum prices affecting cash flow stability
high - The aluminum industry is closely tied to economic growth, particularly in construction and manufacturing, making it sensitive to GDP fluctuations.
Higher interest rates can increase financing costs for capital expenditures, impacting profitability and expansion plans.
minimal - The company has a manageable debt-to-equity ratio of 0.31, indicating limited reliance on credit.
value - Investors may be attracted due to low valuations relative to historical performance, despite current struggles.
high - The stock has exhibited high volatility, particularly with a recent 3-month return of -29.0%.